Autolus Therapeutics (AUTL)
NASDAQ: AUTL
· Real-Time Price · USD
1.73
-0.12 (-6.49%)
At close: Aug 15, 2025, 3:59 PM
1.76
1.73%
After-hours: Aug 15, 2025, 07:55 PM EDT
Autolus Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -70.16M | -27.61M | -82.09M | -58.27M | -52.69M | -77.17M | -45.85M | -45.55M | -39.81M | -26.95M | -42.77M | -42.06M | -37.06M | -41.67M | -33.99M | -33.17M | -33.27M |
Depreciation & Amortization | 2.28M | 2.08M | 1.94M | 1.9M | 1.81M | 1.77M | 1.38M | 1.51M | 1.9M | 1.65M | 1.79M | 1.92M | 2.07M | 2.1M | 2.45M | 2.24M | 1.66M |
Stock-Based Compensation | 2.87M | 6.23M | 4.02M | 2.94M | 2.28M | 3.27M | 2.86M | 2.66M | 2.41M | 3.42M | 3.34M | 2.92M | 2.34M | 7.83M | 1.5M | 1.28M | -670K |
Other Working Capital | 4.87M | -3.32M | 1.73M | -8.58M | -15.07M | 21.41M | -6.46M | -1.85M | -12.3M | 9.46M | -1.46M | -341K | -3.72M | 21.91M | -4.94M | -7.36M | -5.47M |
Other Non-Cash Items | 6.66M | -15.79M | -2.44M | 11.2M | 26.65M | 26.92M | 11.31M | 1.68M | 5.8M | -2.57M | 7.12M | 7.05M | 1.79M | 1.09M | 1K | 5.77M | 683K |
Deferred Income Tax | 487K | 141K | -168K | 74K | -232K | -466K | -238K | -87K | -195K | 319K | -160K | -253K | -174K | -420K | 233K | 395K | -280K |
Change in Working Capital | -17.7M | -2.99M | 2M | -8.92M | -13.75M | 20.83M | -9.65M | 1.64M | -12.52M | 9.57M | -1.22M | -388K | -3.99M | 21.91M | -4.94M | -7.36M | -5.47M |
Operating Cash Flow | -75.56M | -37.93M | -76.74M | -51.08M | -40.51M | -24.83M | -40.19M | -38.15M | -42.42M | -14.57M | -31.9M | -30.81M | -35.03M | -9.16M | -34.75M | -36.61M | -37.34M |
Capital Expenditures | -8.24M | -23.86M | -9.59M | -841K | -533K | -1.48M | -1.5M | -4.39M | -3.62M | -633K | -6.8M | -2.64M | -771K | -1.58M | -3.86M | -1.51M | -1.9M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -71.3M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 20M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | -372.48M | n/a | n/a | n/a | -10.99M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -59.55M | -383.59M | -9.59M | -841K | -533K | -1.48M | -1.5M | -4.39M | -3.62M | -633K | -6.8M | -2.64M | -771K | -1.58M | -3.86M | -1.51M | -1.9M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 30.01M | 185K | -2.08M | 11.46M | 23K | 4K | -219K | -691K | 59.66M | 102K | 1K | -1K | 147.41M | n/a | -5.98M | -130.9M |
Financial Cash Flow | n/a | 30.01M | 185K | -2.08M | 561.44M | 23K | 4K | -219K | -691K | 223.51M | 102K | n/a | -1K | 147.41M | -230K | 13.55M | 123.32M |
Net Cash Flow | -131.55M | -429.73M | -48.42M | -52.59M | 519.21M | -17.28M | -50.98M | -35.52M | -39.41M | 219.39M | -53.39M | -52.13M | -41.78M | 137.41M | -43.29M | -23.24M | 85.71M |
Free Cash Flow | -83.81M | -61.79M | -86.33M | -51.92M | -41.05M | -26.31M | -41.69M | -42.54M | -46.04M | -15.2M | -38.7M | -33.45M | -35.8M | -10.74M | -38.61M | -38.12M | -39.24M |